DS

David Sidransky

The Johns Hopkins University: 19 patents #40 of 4,416Top 1%
JM Johns Hopkins University School Of Medicine: 16 patents #5 of 255Top 2%
GE Genzyme: 2 patents #327 of 891Top 40%
OR Orgenesis: 1 patents #4 of 6Top 70%
EL Esoterix Genetic Laboratories: 1 patents #4 of 11Top 40%
US US Dept of Health & Human Services: 1 patents #1,144 of 3,044Top 40%
IM Immunome: 1 patents #6 of 29Top 25%
JM John Hopkins University, School Of Medicine: 1 patents #7 of 55Top 15%
📍 Pikesville, MD: #2 of 104 inventorsTop 2%
🗺 Maryland: #385 of 35,612 inventorsTop 2%
Overall (All Time): #80,908 of 4,157,543Top 2%
39
Patents All Time

Issued Patents All Time

Showing 1–25 of 39 patents

Patent #TitleCo-InventorsDate
12233072 Compositions comprising bisfluoroalkyl-1,4-benzodiazepinone compounds for treating Adenoid Cystic Carcinoma 2025-02-25
10888549 Pharmaceutical agents targeting cancer stem cells Mohammad O. Hoque, Akira Oki 2021-01-12
10835598 Prophylactic protection against viral infections, particularly HIV Jamie Sulley, Luis Squiquera, Tom Hodge 2020-11-17
10801071 TGF(β)-MIR200-MIG6 pathway and its use in the treatment of cancer as an indicator of resistance to EGFR inhibitors Eugene Izumchenko 2020-10-13
10457992 Hypermethylation biomarkers associated with poor survival outcomes for head and neck squamous cell cancer Rafael Guerrero-Preston, Christina Michailidi 2019-10-29
10428391 Method to use viral and host methylation markers for cervical cancer screening and triage in liquid prep, serum/plasma, and urine: PCR and sequencing based process methods Rafael Guerrero-Preston 2019-10-01
9809864 Dual sequence-capture method for quantifying trans renal HPV DNA in urine Rafael Guerrero Preston, Anne Jedlicka 2017-11-07
9328379 Hypermethylation biomarkers for detection of head and neck squamous cell cancer Rafael Guerrero-Preston, Ethan Soudry 2016-05-03
8859468 Hypermethylation biomarkers for detection of cervical cancer Rafael Guerrero-Preston, Priscilla Brebi-Mieville 2014-10-14
8728732 Global DNA hypomethylation and biomarkers for clinical indications in cancer Rafael Guerrero-Preston 2014-05-20
8617809 Neoplasia screening compositions and methods of use 2013-12-31
8067240 Methods for the diagnosis and treatment of lung cancer Jin Jen, Gary A. Beaudry, Stephen Madden, Arthur H. Bertlesen 2011-11-29
7923460 BRAF mutation T1796A in thyroid cancers Yoram Cohen, Mingzhao Michael Xing 2011-04-12
7846667 Methods for the diagnosis and treatment of lung cancer Jin Jen, Gary A. Beaudry, Stephen Madden, Arthur H. Bertlesen 2010-12-07
7794929 Genomic screen for epigenetically silenced genes associated with cancer Stephen B. Baylin, James G. Herman, Hiromu Suzuki 2010-09-14
7781161 Genomic screen for epigenetically silenced tumor suppressor genes Stephen B. Baylin, James G. Herman, Hiromu Suzuki 2010-08-24
7709202 Molecular characteristics of non-small cell lung cancer Mariana Nacht, Tatiana Dracheva, Stephen Madden, Jin Jen 2010-05-04
7601521 Detection of nucleic acid mutation associated with cancer by analysis of saliva 2009-10-13
7524633 Method of detection of prostate cancer 2009-04-28
7468425 p40 protein acts as an oncogene Jin Jen, Barry Trink, Edward A. Ratovitski 2008-12-23
7378233 BRAF mutation T1796A in thyroid cancers Yoram Cohen, Mingzhao Michael Xing 2008-05-27
7332590 Molecular characteristics of non-small cell lung cancer Mariana Nacht, Tatiana Dracheva, Stephen Madden, Jin Jen 2008-02-19
7319023 Detection of hypermutable nucleic acid sequence in tissue 2008-01-15
7279312 Nucleic acid mutation detection by analysis of saliva 2007-10-09
7252935 Method of detection of prostate cancer 2007-08-07